The iShares Biotechnology ETF (IBB) made its debut on 02/05/2001, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market. For a long ...

In particular, the iShares Nasdaq Biotechnology ETF (NASDAQ: IBB) offers a diversified portfolio of biotech stocks that gives you complete coverage of the sector. Since going through a major ...

According to the iShares Biotechnology ETF’s website, the P/E ratio is 24.43, while the P/B ratio is 4.26. In terms of technical analysis, the share price chart shows the appearance of a bullish ...

iShares Biotechnology ETF earns an Average Process Pillar rating. Morningstar's algorithmically assigned Passive Process ratings are first formulated by comparing the historical efficacy of ...

Any pullbacks in IBB should be bought for long-term equity appreciation. IBB is the iShares Biotechnology ETF. IBB tracks the investment performance of an index composed of U.S.-listed equities in ...

iShares Biotechnology ETF earns an Average Process Pillar rating. Morningstar's algorithmically assigned Passive Process ratings are first formulated by comparing the historical efficacy of ...